Zenon™ Human IgG Labeling Kits
New Zenon Alexa Fluor Plus Labeling Reagents are superior in three ways: improved bioconjugation for brighter signal, redesigned protein for robust screening regardless of IgG isotype, and new, more sensitive fluorophores.
Zenon™ Human IgG Labeling Kits
Invitrogen™

Zenon™ Human IgG Labeling Kits

Take advantage of a fast, versatile, and reliable method for producing antibody (IgG) conjugates for immunocytochemistry (ICC), immunohistochemistry (IHC), flow cytometry, and cell imaging with the Invitrogen Zenon™ Human IgG Labeling Kits.
Have Questions?
보기 방식 변경buttonViewtableView
카탈로그 번호수량여기/방출라벨 또는 염료
Z25455
Z-25455으로도 사용됨
25 Reactions kit496, 546, 565/578 nmR-PE (R-Phycoerythrin)
Z25402
Z-25402으로도 사용됨
50 Reactions kit495/519 nmAlexa Fluor 488
Z25407
Z-25407으로도 사용됨
50 Reactions kit590/617 nmAlexa Fluor 594
Z2540850 Reactions kit650/668 nm
Z25451
Z-25451으로도 사용됨
25 Reactions kit650/660 nmAPC (Allophycocyanin)
카탈로그 번호 Z25455
Z-25455으로도 사용됨
제품 가격(KRW)
710,000
Online offer
Ends: 31-Mar-2026
835,000
할인액 125,000 (15%)
1 kit
카트에 추가하기
수량:
25 Reactions kit
여기/방출:
496, 546, 565/578 nm
라벨 또는 염료:
R-PE (R-Phycoerythrin)
제품 가격(KRW)
710,000
Online offer
Ends: 31-Mar-2026
835,000
할인액 125,000 (15%)
1 kit
카트에 추가하기
Take advantage of a fast, versatile, and reliable method for producing antibody (IgG) conjugates for immunocytochemistry (ICC), immunohistochemistry (IHC), flow cytometry, and cell imaging with the Invitrogen Zenon™ Human IgG Labeling Kits. Simplify your laboratory applications and reduce antibody cross-reactivity while also achieving efficient labeling of antibodies in serum, ascites fluid, or hybridoma suspensions.

Achieve fast, versatile, and reliable fluorophore-, biotin-, or enzyme-labeled IgG primary antibodies with the Invitrogen Zenon™ Human IgG Labeling Kits. These kits utilize Alexa Fluor fluorophores, biotin, or enzymes such as R-phycoerythrin and allophycocyanin, which are attached to monovalent, affinity purified Fab fragments. The Fab fragments, in turn, are directed against and bind with the Fc portion of IgG primary antibodies. Only a small amount of starting material is required, and the method is optimized for efficient labeling of antibodies in serum, ascites fluid, or hybridoma suspensions. Because the Zenon labeling method is based on immunoselectivity, it does not require the removal of exogenous proteins (such as serum) or amine-containing buffers from the target antibody, simplifying the process.

Important features of Zenon labeling technology:
• Labeled antibodies are typically ready to use in 10 minutes
• Requires only 1–20 μg primary antibody
• Simple—no purification required
• Flexible—choose from different fluorophores, biotin, or enzymes.
• Versatile—can be used in a variety of applications including ICC, IHC, flow cytometry, and cell imaging.

Advantages of using Zenon antibody labeling kits:

Cost savings
Zenon antibody labeling kits offer a cost-conscious and reproducible method of tagging as little as 0.4 μg in 2 μL of primary antibody, with minimal waste of expensive or difficult-to-obtain antibodies, or excessive washing steps that pose the risk of product loss.

Sensitivity
Label your primary antibodies without compromising their antigen binding affinity: Zenon dye- and enzyme-labeled Fab fragments, which are targeted to the Fc tail, are affinity purified during their preparation to ensure high affinity and selectivity for the Fc portion of the corresponding primary antibody. The procedure for chemical labeling of the Zenon Fab fragments protects their Fc-binding site, resulting in more active labeling reagents.

Speed
No purification procedure is required prior to using Zenon Fab fragments in your laboratory applications. Formation of the Fab-antibody complex occurs in fewer than five minutes, followed by a five-minute blocking step. During this time, almost all the primary antibody in the mixture is labeled with the labeled Fab fragments.

Simplicity
The Fab-antibody complexes display fluorescence or enzymatic activity that is similar in intensity to that of directly labeled primary antibodies. Varying the extent of the antibody labeling is as simple as changing the amount of added Zenon labeling reagent during the reaction. Once the labeling complexes are formed, they can used immediately, without need for antibody purification.

Reliability
The Zenon Fab-antibody complex is stable and allows subsequent or simultaneous labeling of different target cells and tissues with different complexes. After staining, an aldehyde-based fixing step may be used to prevent the transfer of different labels between different primary antibodies, preserving the initial staining pattern.

Customization
We offer custom antibody conjugation services that are efficient and confidential, and we stand by the quality of our work. We are ISO 13485:2000 certified.

For Research Use Only. Not for use in diagnostic procedures.
사양
색상Red-Orange
여기/방출496, 546, 565/578 nm
라벨 유형PE & APC
라벨링 스케일< 1–20 μg
제품라인Zenon
수량25 Reactions kit
Human
Labeling TargetIgG
라벨 또는 염료R-PE (R-Phycoerythrin)
Unit Size1 kit
구성 및 보관
Contains 1 vial of Zenon R-PE Human IgG labeling reagent (125 μL), and 1 vial of Zenon blocking reagent (human IgG, 125 μL).

Store in refrigerator (2–8°C) and protect from light.

인용 및 참조 문헌 (2)

인용 및 참조 문헌
Abstract
Novel designs of multivalent anti-CD20 humanized antibodies as improved lymphoma therapeutics.
Authors:Rossi EA, Goldenberg DM, Cardillo TM, Stein R, Wang Y, Chang CH,
Journal:Cancer Res
PubMed ID:18922911
'Multivalent antibodies, either monospecific or bispecific, may improve the efficacy of current therapeutic interventions involving a single monoclonal antibody (mAb). We have applied the Dock-and-Lock (DNL) method, a new platform technology for the site-specific and covalent assembly of modular components into stably tethered complexes of defined composition, to prepare a ... More
A general process for the development of peptide-based immunoassays for monoclonal antibodies.
Authors:Sanchez AB, Nguyen T, Dema-Ala R, Kummel AC, Kipps TJ, Messmer BT,
Journal:Cancer Chemother Pharmacol
PubMed ID:20087593
'PURPOSE: Monoclonal antibodies (mAb) are an important and growing class of cancer therapeutics, but pharmacokinetic analyses have in many cases been constrained by the lack of standard and robust pharmacologic assays. The goal of this project was to develop a general method for the production of immunoassays that can measure ... More